Chase AIPricingFAQs
Display currency
Loading news…

Enzytech

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Cambridge, Massachusetts, United States Founded 1987 For Profit

Enzytech is a health care company that develops an injectable drug system for multiple sclerosis patients.

Enzytech was acquired by Alkermes in 1993.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Founded
1987
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
HQ
Cambridge, Massachusetts, United States
Region
Greater Boston Area, East Coast, New England
Exit date
Jan 1, 1993
Closed
May 21, 1993

Signals & Scores

Heat score
Low
Trend (7d)
0
Trend (30d)
-0.4
Trend (90d)
-0.3

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Enzytech

Loading news…

FAQs about Enzytech

People who checked this page also checked these

Browse the full Acquirezy directory.
Enzytech - Company Profile, Full Acquisitions List, Funding and Investments